1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea

ID: ALA1213925

PubChem CID: 46919121

Max Phase: Preclinical

Molecular Formula: C24H23ClF3N3O3

Molecular Weight: 493.91

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)Nc1ccc(OCCN2CCOCC2)c2ccccc12

Standard InChI:  InChI=1S/C24H23ClF3N3O3/c25-20-6-5-16(15-19(20)24(26,27)28)29-23(32)30-21-7-8-22(18-4-2-1-3-17(18)21)34-14-11-31-9-12-33-13-10-31/h1-8,15H,9-14H2,(H2,29,30,32)

Standard InChI Key:  IKJIRGXOQLNWKM-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    3.9542  -16.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9583  -16.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8083  -14.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3792  -14.8083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0917  -14.3917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3375  -14.4000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500  -14.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5208  -14.3833    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6667  -15.6083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375  -15.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9083  -15.6375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0500  -15.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2375  -14.7958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8125  -15.6250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3792  -15.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2458  -17.2667    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    4.6750  -17.2625    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.9542  -17.6750    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3375  -16.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3375  -14.8042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6583  -14.7792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9417  -14.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3833  -16.0167    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   -1.7667  -16.0500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1958  -16.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4792  -15.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6250  -16.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9083  -14.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3417  -13.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7583  -14.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6167  -14.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3375  -15.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7625  -13.5875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0542  -13.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  8  1  0
  4  5  1  0
  5  3  1  0
  6  4  2  0
  7  6  1  0
  8 13  1  0
  9  1  2  0
 10  1  1  0
 11 25  1  0
 12  7  2  0
 13 10  2  0
 14  3  2  0
 15  4  1  0
 16  2  1  0
 17  2  1  0
 18  2  1  0
 19 15  2  0
 20 31  1  0
 21  9  1  0
 22 21  2  0
 23  9  1  0
 24 12  1  0
 25 26  1  0
 26 24  1  0
 27 11  1  0
 28 11  1  0
 29  6  1  0
 30  7  1  0
 31 28  1  0
 32 27  1  0
 33 34  1  0
 34 29  2  0
 13 22  1  0
 19 12  1  0
 30 33  2  0
 32 20  1  0
M  END

Associated Targets(Human)

BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Abl1 Tyrosine-protein kinase ABL (212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 493.91Molecular Weight (Monoisotopic): 493.1380AlogP: 5.87#Rotatable Bonds: 6
Polar Surface Area: 62.83Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.39CX Basic pKa: 6.78CX LogP: 5.23CX LogD: 5.14
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.45Np Likeness Score: -1.86

References

1. Dietrich J, Hulme C, Hurley LH..  (2010)  The design, synthesis, and evaluation of 8 hybrid DFG-out allosteric kinase inhibitors: a structural analysis of the binding interactions of Gleevec, Nexavar, and BIRB-796.,  18  (15): [PMID:20621496] [10.1016/j.bmc.2010.05.063]

Source